BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2670357)

  • 1. The role of cytochromes P-450 and N-acetyl transferase in the carcinogenicity of aromatic amines and amides.
    McManus ME
    Clin Exp Pharmacol Physiol; 1989 Jun; 16(6):491-5. PubMed ID: 2670357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal N- and C-oxidations of carcinogenic aromatic amines and amides.
    Lotlikar PD; Hong YS
    Natl Cancer Inst Monogr; 1981 Dec; (58):101-7. PubMed ID: 7341966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of aromatic amines and amides with chemical models for cytochrome P450 in Ames assay.
    Inami K; Okazawa M; Mochizuki M
    Toxicol In Vitro; 2009 Sep; 23(6):986-91. PubMed ID: 19563884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation of aromatic amines and dialkylnitrosamines.
    Lotlikar PD
    J Cancer Res Clin Oncol; 1981; 99(1-2):125-36. PubMed ID: 7251630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic activation of aromatic amines and azo dyes.
    Bartsch H
    IARC Sci Publ; 1981; (40):13-30. PubMed ID: 6799396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.
    Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF
    Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies.
    Windmill KF; McKinnon RA; Zhu X; Gaedigk A; Grant DM; McManus ME
    Mutat Res; 1997 May; 376(1-2):153-60. PubMed ID: 9202751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.
    Butler MA; Iwasaki M; Guengerich FP; Kadlubar FF
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7696-700. PubMed ID: 2813353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes.
    Hammons GJ; Milton D; Stepps K; Guengerich FP; Tukey RH; Kadlubar FF
    Carcinogenesis; 1997 Apr; 18(4):851-4. PubMed ID: 9111224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of high sensitive umu test system: rapid detection of genotoxicity of promutagenic aromatic amines by Salmonella typhimurium strain NM2009 possessing high O-acetyltransferase activity.
    Oda Y; Yamazaki H; Watanabe M; Nohmi T; Shimada T
    Mutat Res; 1995 Apr; 334(2):145-56. PubMed ID: 7885366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function and localization of cytochromes P450 involved in the metabolic activation of food-derived heterocyclic amines.
    McKinnon RA; McManus ME
    Princess Takamatsu Symp; 1995; 23():145-53. PubMed ID: 8844805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfotransferase- and acetyltransferase-mediated activation of carcinogenic N-hydroxyarylamines in mammals and bacteria, and their modulation by thiols.
    Yamazoe Y; Abu-Zeid M; Staiano N; Kato R
    Basic Life Sci; 1993; 61():161-9. PubMed ID: 8304927
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.
    Turesky RJ; Le Marchand L
    Chem Res Toxicol; 2011 Aug; 24(8):1169-214. PubMed ID: 21688801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines.
    Turesky RJ
    Curr Drug Metab; 2004 Apr; 5(2):169-80. PubMed ID: 15078194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation and persistence of arylamine DNA adducts in vivo.
    Beland FA; Kadlubar FF
    Environ Health Perspect; 1985 Oct; 62():19-30. PubMed ID: 4085422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-hydroxylation of carcinogenic and mutagenic aromatic amines.
    Kato R; Kamataki T; Yamazoe Y
    Environ Health Perspect; 1983 Mar; 49():21-5. PubMed ID: 6832094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive forms of aromatic amines and amides: chemical and structural features in relation to carcinogenesis.
    Kriek E
    Prog Clin Biol Res; 1983; 132B():161-74. PubMed ID: 6634753
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.
    Kadlubar FF; Butler MA; Kaderlik KR; Chou HC; Lang NP
    Environ Health Perspect; 1992 Nov; 98():69-74. PubMed ID: 1486865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of aromatic amines by human pancreas.
    Anderson KE; Hammons GJ; Kadlubar FF; Potter JD; Kaderlik KR; Ilett KF; Minchin RF; Teitel CH; Chou HC; Martin MV; Guengerich FP; Barone GW; Lang NP; Peterson LA
    Carcinogenesis; 1997 May; 18(5):1085-92. PubMed ID: 9163700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation and effects of the food-derived heterocyclic amines in extrahepatic tissues.
    Overvik E; Hellmold H; Branting C; Gustafsson JA
    Princess Takamatsu Symp; 1995; 23():123-33. PubMed ID: 8844803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.